MIRA vs TSLA · $41.1M cap vs P/E 179, rev $94.83B
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) versus Tesla Inc (TSLA) — a side-by-side from cached financials, not a winner call.
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is a drug manufacturers - general company listed on NASDAQ.
Tesla Inc (TSLA) is a auto manufacturers company listed on US. It is led by Elon R. Musk.
MIRA does not have a complete income-statement cache yet.
Latest reported TSLA revenue for 2025-12-31 was $94.83B. Net income was $3.79B. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
MIRA currently screens at market cap $41.1M. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
Not investment advice. Open the MIRA and TSLA stock pages for the full models.
Not investment advice.